Investigators Awarded U34/R34 Funding


    The Clinical Trials Development Resource for Hematologic Disorders will provide consultative services for the development of multi-site clinical trials to grantees of the Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34) (RFA-HL-12-023) program and to grantees of the NHLBI Clinical Trial Pilot Studies (R34) (PAR-16-037) program.
  • Deadlines for submission of new R34 application are February 16, June 16, and October 16, 2018.
  • Deadlines for resubmission or revision of R34 application are March 16, July 16, November 16, 2018.



     About Us    Awarded Funding  Seeking Funding  Links   Contact Us
Accessible Banner Information
For Questions or Comments about the website, email